Skip to content

Effects of Curcumin on Diabetic Foot Treatment

The Effects of Curcumin on the Improvement of Diabetic Foot Ulcer

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210413050958N4
Enrollment
35
Registered
2022-05-16
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot. Diabetes mellitus due to underlying condition with foot ulcer

Interventions

Intervention 1: Intervention group: The treatment group (n= 35) including patients with grade 3 and 4 diabetic foot ulcers based on Wagner's classification. Curcumin (as C3 complex) at a dose of 500 m

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Signed informed consent form Patients with diabetic foot ulcer grade 3 and 4 according to the Wagner classification do not require surgery at this stage of wound healing. Patients with ischemic foot ulcer are not included in the study. Patients with pressure sore are not included in the study. If the patient has renal failure undergoing dialysis, he/she will not be included in the study.

Exclusion criteria

Exclusion criteria: Not referring the patient for subsequent follow-ups so that the nurse can not dress the wound (travel or change the patient's place of residence) Occurrence of any medical problem or surgery not related to wound healing that makes it impossible to continue the study (such as myocardial infarction or stroke, acute limb ischemia, sepsis for any reason other than the patient's wound and etc). Hepatic failure Biliary obstruction

Design outcomes

Primary

MeasureTime frame
Wound healing (wound healing by epithelialization). Timepoint: The depth of the wound will be evaluated before and 100 days after the intervention. Method of measurement: Wound depth is measured using the vernier caliper at the maximum vertical diameter of the wound and wound healing will be determined according to the Wagner criterion.

Secondary

MeasureTime frame
Fasting Blood Glucose. Timepoint: Before and 100 days after the intervention. Method of measurement: Laboratory kit.;HbA1c. Timepoint: Before and 100 days after the intervention. Method of measurement: laboratory kit.;Insulin. Timepoint: Before and 100 days after the intervention. Method of measurement: laboratory kit.;Lipid Profile. Timepoint: Before and 100 days after the intervention. Method of measurement: laboratory kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Saberi-Karimian

Mashhad University of Medical Sciences

saberikm@mums.ac.ir+98 51 3872 2134

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026